NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE8894 Query DataSets for GSE8894
Status Public on Nov 20, 2007
Title Prediction of Recurrence-Free Survival in Postoperative NSCLC Patients—a Useful Prospective Clinical Practice
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Background:
One of the main fields of lung cancer research is identifying patients who are at high risk of post-resection recurrence. Individual recurrence risk evaluation by accurate but simple and reproducible method is needed for the clinical practice.

Results:
The log-rank test and further selection by our criteria of assayability generated 87 genes from microarray data with significant level 5%. Of these, by PTQ-PCR, the expression of most significant 18 genes was obtained. Using these gene expression information and clinical parameters, by stepwise variable selection method, the recurrence prediction model, which composed of 6 genes (CALB1, MMP7, SLC1A7, GSTA1, CCL19, IFI44) and pStage and cell differentiation, were developed. Validation into the two independent cohorts showed good results of the proposed model (p=0.0314, 0.0305, respectively). The predicted median recurrence-free survival times for each patient were reflected real ones well.

Conclusions:
Our method of individualized recurrence risk prediction is accurate, technically simple and reproducible to be used in clinical practice. Therefore, it would be useful in customizing the lung cancer management strategies.
Keywords: Recurrence Free Survival Analysis
 
Overall design Methods:
At first, we selected the statistically significant genes from the analysis of time-to-recurrence and censoring information from 138 whole-genome wide microarray data. Then, we further reduced the number of genes which could be reliably reproducible by RTQ-PCR. With these assayable genes and clinical parameters, construction of recurrence prediction model by Cox proportional hazard regression was done. After validation into two independent cohorts (n=59 and n=56), the model was transformed into recurrence prediction for the each patient.
 
Contributor(s) Son D, Kim S, Jo J, Kim H, Choi YH, Jung Y, Park M, Lim Y, Lee J, Lee E, Kim J
Citation(s) 19010856
Submission date Aug 29, 2007
Last update date Mar 25, 2019
Contact name Jhinkook Kim
E-mail(s) callian@paran.com
Phone 82-2-3410-3753
Fax 82-2-3410-3649
Organization name samsung medical center
Street address 50
City seoul
ZIP/Postal code 135-710
Country South Korea
 
Platforms (1)
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Samples (138)
GSM225465 LUNG CANCER SML011
GSM225530 LUNG CANCER SML007
GSM225544 LUNG CANCER SML008
Relations
BioProject PRJNA102281

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary data files not provided
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap